CORDRAN CREAM Rx
Generic Name and Formulations:
Flurandrenolide 0.025%, 0.05%.
Indications for CORDRAN CREAM:
Adults and Children:
Apply thin film and massage in 2–3 times daily.
Tape: Serum-exuding lesions. Intertrigo.
Treat infection if present; discontinue if infection persists or worsens. Avoid use near eyes. Systemic absorption increased by more potent steroids, prolonged use, use over large surface area, or use of occlusive dressings. Avoid abrupt cessation in chronic use. Occlude only if necessary; do not occlude higher potency products. Do not use tight-fitting diapers or plastic pants on patients. Do not use on face, groin, or axillae. Monitor adrenal function in children if a high potency product or occlusion is used. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, glucosuria, or irritation occurs. Use lowest effective dose and potency (esp. in children). Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infections, skin atrophy, striae, miliaria, other local effects; immunosuppression, masks infections, intracranial hypertension, HPA axis suppression (esp. in children).
Crm 0.025%—30g, 60g, 120g; Crm 0.05%—15g, 30g, 60g, 120g; Lotion—15mL, 60mL, 120mL; Oint 0.05%—15g, 30g, 60g; Tape (roll) 3in x 24in, 3in x 80in—1
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Demoralization Common in Patients With Parkinson Disease
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Migraine a Common Comorbidity in Individuals With Sarcoidosis
- Cardiovascular Risk Factors and Development of Brain Atrophy in Multiple Sclerosis
- Association Between Multiple Sclerosis Relapses and Vaccinations
- Understanding Impulse Control Disorders in Parkinson Disease: Developments and Treatments